{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:18:21Z","timestamp":1783937901922,"version":"3.55.0"},"reference-count":42,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72304060"],"award-info":[{"award-number":["72304060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"published-print":{"date-parts":[[2026,7,3]]},"DOI":"10.1080\/14737167.2026.2691180","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:41:13Z","timestamp":1782110473000},"page":"813-822","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Cost-effectiveness analysis of sacituzumab tirumotecan as second-line therapy for EGFR-TKI\u2013resistant, EGFR-mutated advanced NSCLC in China"],"prefix":"10.1080","volume":"26","author":[{"given":"Jing","family":"He","sequence":"first","affiliation":[{"name":"University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Yu","sequence":"additional","affiliation":[{"name":"University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[{"name":"University of Electronic Science and Technology of China","place":["Chengdu, China"]},{"name":"University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-1515"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.7150\/jca.57711"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2512071"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2019.10.001"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.6987"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43046-025-00298-8"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12627"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01125-3"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13236129"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pccm.2024.08.002"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03638-2"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.11.1351"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2024.0592"},{"key":"e_1_3_5_15_1","volume-title":"Chinese society of clinical oncology (CSCO) guidelines for the diagnosis and treatment of non-small cell lung cancer 2025 [M]","author":"COMMITTEE C S O C O C G W","year":"2025","unstructured":"COMMITTEE C S O C O C G W. Chinese society of clinical oncology (CSCO) guidelines for the diagnosis and treatment of non-small cell lung cancer 2025 [M]. Beijing: People\u2019s Medical Publishing House; 2025."},{"key":"e_1_3_5_16_1","first-page":"1","article-title":"Cost-utility analysis of Sacituzumab Tirumotecan for the treatment of EGFR-Mutated advanced non\u2013small cell lung cancer","author":"Pan MGK","year":"2026","unstructured":"Pan MGK, Ju W, Zhu T, et al. Cost-utility analysis of Sacituzumab Tirumotecan for the treatment of EGFR-Mutated advanced non\u2013small cell lung cancer. Her Med. 2026;1\u201316.","journal-title":"Her Med"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-3-177"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-3-263"},{"key":"e_1_3_5_19_1","unstructured":"Wu J G LIU. Chinese guidelines for pharmacoeconomic evaluations. 2025."},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-9"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X12472398"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-2024-1053"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2468070"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2022.11.008"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1015702"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1563788"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.728440"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70083"},{"issue":"3","key":"e_1_3_5_29_1","first-page":"177","article-title":"Parameter distributions for correlated parameters in pharmacoeconomic probabilistic sensitivity analysis","volume":"37","author":"Wan CQ","year":"2018","unstructured":"Wan CQ, Zeng XH. Parameter distributions for correlated parameters in pharmacoeconomic probabilistic sensitivity analysis. Chin J New Drugs Clin Remedies. 2018;37(3):177\u2013179.","journal-title":"Chin J New Drugs Clin Remedies"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2023.11.003"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2021.01.009"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00971-2"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-025-04834-0"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/17588359251405044"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-025-00801-x"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01679-1"},{"key":"e_1_3_5_37_1","volume-title":"National Reimbursement Drug List (NRDL) \u2013 2025 Edition [R]","author":"Administration N H S","year":"2025","unstructured":"Administration N H S. National Reimbursement Drug List (NRDL) \u2013 2025 Edition [R]. National Healthcare Security Administration; 2025."},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0343330"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13561-025-00700-0"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2025.104550"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.15.1453"},{"key":"e_1_3_5_42_1","unstructured":"Min Jin M. Cost-utility analysis of sacituzumab tirumotecan in previously treated EGFR-mutated NSCLC patients: a Chinese healthcare perspective. 2026."},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1093469"}],"container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2026.2691180","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14737167.2026.2691180","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2026.2691180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:03:09Z","timestamp":1783936989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2026.2691180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,7,3]]}},"alternative-id":["10.1080\/14737167.2026.2691180"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2026.2691180","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-02-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}